Researchers describe a new set of cell surface markers on dopaminergic progenitor cells, which allow isolation of a more beneficial population of induced neurons for cell replacement therapy. Animals that received transplanted cells that had been selected for the new marker fared better than their counterparts with a typical transplant.
Improving cell replacement therapy for Parkinson’s disease
Researchers describe a new set of cell surface markers on dopaminergic progenitor cells, which allow isolation of a more beneficial population of induced neurons for cell replacement therapy. Animals that received transplanted cells that had been selected for the new marker fared better than their counterparts with a typical transplant.
